Literature DB >> 33530239

Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for systematic review and meta-analysis.

Zhongping Shi1, Jun Wang, Shanjiang Chen, Haiyue Dai, Yiwei Huang.   

Abstract

BACKGROUND: Arteriosclerosis has genetic correlation. Many studies have shown that angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism is highly associated with arteriosclerosis, but there is no evidence-based basis. The purpose of this study is to systematically evaluate the relationship between AT1R gene A1166C polymorphism and arteriosclerosis.
METHODS: The search time is set from the establishment of the database in December 2020 in this study. The search database include China National Knowledge Infrastructure (CNKI), Wanfang, VIP and China Biology Medicine disc (CBM), PubMed, EMBASE, Web of Science, and the Cochrane Library. The subjects are observational studies on the relationship between AGTR1 A1166C polymorphism and arteriosclerosis (including case-control study, cross-sectional study, and cohort study). The language is limited to English and Chinese. The data of the included study are extracted and the literature quality is evaluated by 2 researchers independently. The data are statistically analyzed by Stata 16.0 software.
RESULTS: This study will use pulse wave velocity as an index to evaluate arteriosclerosis to explore the relationship between AT1R gene A1166C polymorphism and arteriosclerosis.
CONCLUSION: This study will provide evidence-based medicine for elucidating the genetic tendency of arteriosclerosis. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/V6E2Y.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33530239      PMCID: PMC7850680          DOI: 10.1097/MD.0000000000024407

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  19 in total

1.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

2.  The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

Authors: 
Journal:  J Biol Chem       Date:  2013-02-08       Impact factor: 5.157

3.  Ambulatory arterial stiffness index and its role in assessing arterial stiffness in dialysis patients.

Authors:  Wenjin Liu; Jiajun Zhou; Jianping Chen; Meijuan Meng; Xiurong Li; Chaoqing Gao; Jianmei Zhou; Liang Wang; Zhuxing Sun; Hong Chu; Wei Fan; Youwei Bai; Junwei Yang
Journal:  J Hypertens       Date:  2017-06       Impact factor: 4.844

4.  The relationship between arterial wall stiffness and left ventricular dysfunction.

Authors:  Y Hu; L Li; L Shen; H Gao
Journal:  Neth Heart J       Date:  2013-05       Impact factor: 2.380

5.  A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.

Authors:  Milo A Puhan; Holger J Schünemann; Mohammad Hassan Murad; Tianjing Li; Romina Brignardello-Petersen; Jasvinder A Singh; Alfons G Kessels; Gordon H Guyatt
Journal:  BMJ       Date:  2014-09-24

6.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors: 
Journal:  BMJ       Date:  2016-07-21

7.  Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.

Authors:  A Benetos; S Gautier; S Ricard; J Topouchian; R Asmar; O Poirier; E Larosa; L Guize; M Safar; F Soubrier; F Cambien
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

8.  Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.

Authors:  Giulio Ceolotto; Italia Papparella; Alessia Bortoluzzi; Giacomo Strapazzon; Fabio Ragazzo; Paolo Bratti; Aline S C Fabricio; Elisa Squarcina; Massimo Gion; Paolo Palatini; Andrea Semplicini
Journal:  Am J Hypertens       Date:  2010-10-21       Impact factor: 2.689

Review 9.  The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.

Authors:  Annayya R Aroor; Vincent G Demarco; Guanghong Jia; Zhe Sun; Ravi Nistala; Gerald A Meininger; James R Sowers
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555

10.  Blood pressure, arterial stiffness and endogenous lithium clearance in relation to AGTR1 A1166C and AGTR2 G1675A gene polymorphisms.

Authors:  Marcin Cwynar; Jerzy Gąsowski; Anna Głuszewska; Jarosław Królczyk; Henryk Bartoń; Agnieszka Słowik; Tomasz Grodzicki
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-23       Impact factor: 1.636

View more
  2 in total

1.  Prevalence and risk factors for vascular calcification based on the ankle-brachial index in the general population: a cross-sectional study.

Authors:  Shengnan Chen; Ning Li; Yajuan Gao; Hongli Jiang; Yan Shen
Journal:  BMC Cardiovasc Disord       Date:  2022-05-18       Impact factor: 2.174

2.  The Genetic Variants in the Renin-Angiotensin System and the Risk of Heart Failure in Polish Patients.

Authors:  Iwona Gorący; Anna Gorący; Mariusz Kaczmarczyk; Jakub Rosik; Klaudyna Lewandowska; Andrzej Ciechanowicz
Journal:  Genes (Basel)       Date:  2022-07-15       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.